MicroTech Medical (Hangzhou) Co., Ltd. (HKG:2235)

HKG:2235 Financials Overview

Financials in millions CNY. Fiscal year is January - December.

Revenue & Profits

Chart

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Revenue Revenue Growth	828.99	660.79	345.62	253.23	173.61	151.4
Revenue Growth	25.45%	91.19%	36.48%	45.86%	14.67%	101.13%
Gross Profit Gross Profit Growth	460.27	348.31	179.08	117.14	79.69	70.88
Operating Income Operating Income Growth	75.86	-0.89	-135.52	-195.29	-120.34	-60.17
Net Income Net Income Growth	82.72	40.15	-63.12	-125.02	-35.04	-48.15
Earnings Per Share EPS Growth	0.21	0.10	-0.15	-0.29	-0.08	-0.13
EPS Growth	120.93%	-	-	-	-	-

Revenue by Geography

Chart

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Mainland China Mainland China Growth	313.37	313.37	236.69	170.89	128.13	107.29
Other Countries/Regions Other Countries/Regions Growth	343.35	343.35	104.95	78.41	42.24	44.12
Total Total Growth	656.72	656.72	341.64	249.3	170.37	151.4

Cash & Debt

Chart

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Investments Cash & Investments Growth	1,538	1,546	1,707	1,892	2,047	2,151
Total Debt Total Debt Growth	74.27	64.79	0.17	0.64	0.72	0.26
Net Cash (Debt) Net Cash Growth	1,464	1,481	1,707	1,891	2,046	2,151
Net Cash Growth	-1.17%	-13.25%	-9.73%	-7.56%	-4.88%	228.42%
Net Cash Per Share Net Cash Per Share Growth	3.79	3.58	4.06	4.39	4.67	5.76

Cash Flow & CapEx

Chart

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Operating Cash Flow Operating Cash Flow Growth	-	32.61	-120.65	-153	-119.01	-44.22
Capital Expenditures CapEx Growth	-	-38.92	-83.24	-	-29.78	-17.6
Free Cash Flow Free Cash Flow Growth	-	-6.31	-203.88	-153	-148.79	-61.82
Free Cash Flow Growth	-	-	-	-	-	-

Margins

Chart

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Gross Margin	55.52%	52.71%	51.81%	46.26%	45.91%	46.82%
Operating Margin	9.15%	-0.14%	-39.21%	-77.12%	-69.32%	-39.74%
Pretax Margin	10.02%	6.11%	-18.27%	-49.30%	-20.18%	-31.80%
Profit Margin	9.98%	6.08%	-18.26%	-49.37%	-20.18%	-31.80%
FCF Margin	-	-0.95%	-58.99%	-60.42%	-85.71%	-40.83%

Valuation

Chart

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug 22, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
PE Ratio	28.85	74.18	-	-	-	-
Forward PE	30.65	61.27	-	-	-	-
PS Ratio	3.10	4.51	6.95	9.69	21.15	58.19

Data Source: S&P Global Market Intelligence Last updated: Dec 31, 2025

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Aug 21, 2026

Data Sources Report a data error